We are a Washington state based research peptide business dedicated to bringing you quality GLP1’s. (glucodone like peptides)

Glucagon-like peptide-1 (GLP-1) agonists are a class of medications utilized to treat type 2 diabetes mellitus (T2DM) and obesity. As a class of medications, they are among several pharmacological options for these endocrine diseases.. Glp1s regulate blood sugar, slow down digestion and send the signal to your brain that your stomach is full.
Glp1 peptides are getting quite popular. They are the only thing out there that rivals the gastric bypass surgery. Without surgery.

Tirzepatide is a Glp1 peptide that also contains an added component ; a GIC component. These gastro intestinal components work to slow down digestion even more, so food flows through your body slower, thus helping you get the most out of what you eat and stay fuller, longer.

Beginning in the 1950’s, the U.S. Food and Drug Administration embarked on a mission to reframe the public’s conception of a healthy diet. To do this, one would assume that the F.D.A. employed independent, unaffiliated scientists to conduct exhaustive research on nutrition, then passed their findings on to the public for them to apply this knowledge to improve their dietary practices. Their motivations were far more nuanced and complex than that. The information given to the public was a product of bad science: scientists representing the private interests of corporate agriculture and big pharma performed subpar research which led to incomplete or erroneous data and the dissemination of misinformation.

The best-known product of this initiative, the Food Pyramid, became the standard guide for “healthy” eating. Whereas peer-reviewed clinical trials should have formed the entirety of the data gleaned from the study, corporate and political interests were allowed to interfere. For example: Richard Nixon had a contract with the Soviet Union agreeing to sell them millions of bushels of grain. However, a terrible growing season resulted in an insufficient grain supply, impacting our ability to fulfill that contractual obligation and leading to a grain scarcity for the public at home as well. Grain prices soared, and public outcry ensued. To resolve this scarcity and prevent it from happening in the future, Nixon passed a number of policies designed to increase grain production quickly. And they worked- so much so that before long we had immense surpluses of grain. This is how, despite no research supporting their doing so, the F.D.A gave grains an unduly large portion of the Food Pyramid.

The vilification of dietary fat consumption was yet another outcome of private interests impacting our diets. With an exponentially rising rate of heart disease in the United States, we were inundated by ever-evolving guidelines telling us how to avoid it… Cut the fatty portion off of your steaks. No more egg yolks. More cereal! More grains! More bread! By the 1990’s processed foods dominated grocery stores and restaurants. Products purported to be “heart healthy” contained enormous quantities of sugar.

Chemicals found their way into everything, despite natural alternatives existing. Many of the chemicals in U.S. foods are banned in multiple countries throughout the world. If you compare the processed foods found in the U.S. With their European and Canadian counterparts, you will find that the American versions contain many unnecessary ingredients- often those banned elsewhere.

Tirzepatide is a dual GIP/GLP-1 receptor co-agonist (a receptor co-agonist is a molecule that, when binding to a receptor alongside another molecule that is also considered a co-agonist, work together to produce a biological response). It is an acylated peptide (a peptide that has been modified with a fatty acid side chain through a process called acylation) engineered to activate the GIP/GLP-1 receptors, key mediators of insulin secretion that are also expressed in regions of the brain that regulate food intake.

The gastric inhibitory polypeptide receptor [GIPR] is a G-protein coupled receptor that binds to the hormone gastric inhibitory polypeptide (GIP). GIP is released by the small intestine in response to food, and GIPR is found on pancreatic beta cells. When GIP binds to GIPR, it stimulates insulin secretion, which helps to control blood glucose levels. GIPR plays a role in many biological processes, including insulin secretion, bone formation, fat deposition, and pancreatic beta cell proliferation.

Average weight loss is between 5-26.6% of Total Body Weight, with most significant weight loss after 52-88 weeks.

All medications will be accompanied with instructions for reconstitution and a dosage chart. If you still have questions after reading our instructions, please contact us for further assistance. Once reconstituted, these medications must be stored at temperatures between 36º and 46º Fahrenheit.

Once your payment has processed, we ship the following day (same day shipping when possible).

All orders are shipped vis USPS Priority Mail, and usually arrive within 3-5 business days. If your product arrived broken, or the package is lost, we will replace it, no questions asked. Our company’s integrity is of the utmost importance.

Both Semaglutide (brand names Ozempic, Wegovy) and Tirzepatide (Mounjaro, Zepbound) are a class of medications called GLP-1 (Glucagon-like Peptide-1) receptor agonists, designed to treat Type 2 Diabetes Mellitus (T2DM) and Obesity. These medications mimic the action of a hormone called glucagon-like peptide 1, which increases insulin

secretion, decreases glucagon release, and slows gastric emptying. They are the only thing on the market with results rivaling that of gastric-bypass surgery, but without having to undergo a surgical procedure. While there are numerous other pharmacological options to treat these diseases, these two are the most popular options for weight loss.

These medications are injected subcutaneously in either the stomach (minimum of 3” from the belly button on either side), thigh, or back of the arm. It is important to rotate injection sites. Always prep the skin with medical-grade alcohol.

Tirzepatide is a dual GIP/GLP-1 receptor co-agonist (a receptor co-agonist is a molecule that, when binding to a receptor alongside another molecule that is also considered a co-agonist, work together to produce a biological response). It is an acylated peptide (a peptide that has been modified with a fatty acid side chain through a process called acylation) engineered to activate the GIP/GLP-1 receptors, key mediators of insulin secretion that are also expressed in regions of the brain that regulate food intake.

The gastric inhibitory polypeptide receptor [GIPR] is a G-protein coupled receptor that binds to the hormone gastric inhibitory polypeptide (GIP). GIP is released by the small intestine in response to food, and GIPR is found on pancreatic beta cells. When GIP binds to GIPR, it stimulates insulin secretion, which helps to control blood glucose levels. GIPR plays a role in many biological processes, including insulin secretion, bone formation, fat deposition, and pancreatic beta cell proliferation.

Average weight loss is between 5-26.6% of Total Body Weight, with most significant weight loss after 52-88 weeks.

Operates much like Tirzepatide, but without the added hormone called Glucose-Dependent Insulinotropic Polypeptide (GIP). Key benefits include weight loss, enhanced blood sugar control, and cardiovascular benefits including a reduced risk of heart attack and stroke in people at high risk for these. Average weight loss is between 5-16% of Total Body Weight with most individuals experiencing significant weight loss after one year of treatment.

Individual Variation

It is vital to understand that not everyone will experience the same amount of weight loss. Results may vary depending on factors such as starting weight and adherence to treatment. Some may see minimal results. Please note that these medications take several weeks to reach a steady state in your system. The initial dosing schedule is designed to allow your body to adapt to the medication prior to raising to a therapeutic dosage level. Significant weight loss is usually observed over several months of consistent use.

Lifestyle Changes

Combining a GLP-1 with a healthy diet and in combination with regular exercise maximizes overall weight loss potential.

Possible Side Effects

*Nausea

*Vomiting

*Diarrhea

*Constipation

*Indigestion

*Abdominal Pain

*Bloating

*Fatigue

*Appetite Loss

*Burping (“sulphur burps”)

*Hypoglycemia (low blood sugar levels)

*Behavioral Changes

*Hair Loss

*Injection Site Reaction

*Gallbladder Disease

*Kidney Disease